🔎 Trials Near Me

Gara Jalqabaatti › Lymphoma B-Cell › Michigan › Ann Arbor

Qorannoo klinikaalii Lymphoma B-Cell Ann Arbor, MI keessatti

Qorannoo 5 Lymphoma B-Cell f Ann Arbor fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Namoota walitti qabaa jiraSadarkaa 3
  • University of Michigan, Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06742996

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Namoota walitti qabaa jiraSadarkaa 1
  • University of Michigan Comprehensive Cancer Center, Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07101328

Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
  • University of Michigan Rogel Cancer Center, Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ado-2026 · NCT07532525

DALY II USA/ MB-CART2019.1 for DLBCL

Namoota walitti qabaa jiraSadarkaa 2
  • University of Michigan, Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT04792489

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • C.S. Mott Children's Hospital, Ann Arbor
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 06-Mud-2024 · NCT05476770

Qorannoo Lymphoma B-Cell magaalota biroo keessatti

Qorannoo biroo Ann Arbor keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.